High Tech Pharm Co. Ltd (106190) — Cash Flow-to-Debt Ratio
High Tech Pharm Co. Ltd (106190) has a Cash Flow-to-Debt Ratio of 0.52x as of September 2025, meaning its operating cash flow of ₩6.60 Billion could theoretically repay 1% of its total liabilities (₩12.57 Billion) in one year. See High Tech Pharm Co. Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
High Tech Pharm Co. Ltd Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for High Tech Pharm Co. Ltd across 11 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of High Tech Pharm Co. Ltd.
Annual Cash Flow-to-Debt Ratio for High Tech Pharm Co. Ltd (2014–2024)
Year-by-year debt coverage analysis for High Tech Pharm Co. Ltd. Check High Tech Pharm Co. Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.72x | ₩14.69 Billion | ₩20.35 Billion | ▲ +596.5% |
| 2023 | 0.10x | ₩2.91 Billion | ₩28.06 Billion | ▲ +190.3% |
| 2022 | -0.11x | ₩-3.70 Billion | ₩32.26 Billion | ▼ -148.1% |
| 2021 | 0.24x | ₩6.93 Billion | ₩29.05 Billion | ▲ +203.3% |
| 2020 | -0.23x | ₩-7.69 Billion | ₩33.30 Billion | ▼ -408.1% |
| 2019 | 0.07x | ₩2.48 Billion | ₩33.14 Billion | ▼ -58.7% |
| 2018 | 0.18x | ₩5.38 Billion | ₩29.65 Billion | ▼ -43.8% |
| 2017 | 0.32x | ₩5.45 Billion | ₩16.90 Billion | ▲ +281.7% |
| 2016 | 0.08x | ₩1.45 Billion | ₩17.13 Billion | ▼ -90.5% |
| 2015 | 0.89x | ₩12.71 Billion | ₩14.23 Billion | ▲ +27.6% |
| 2014 | 0.70x | ₩10.17 Billion | ₩14.53 Billion | — |